Align Technology | ALGN - Selling And Administration Expenses

Stock Price
189.59
Daily Change
-1.08 -0.57%
Monthly
5.17%
Yearly
3.40%
Q2 Forecast
185.89

Align Technology reported $441.68M in Selling and Administration Expenses for its fiscal quarter ending in December of 2025.





Selling And Administration Expenses Change Date
3M USD 744M 221M Mar/2026
Align Technology USD 441.68M 23.88M Dec/2025
Becton, Dickinson and Co. USD 1.39B 27M Dec/2025
Bruker USD 247.2M 4.7M Dec/2025
Cardinal Health USD 1.5B 43M Dec/2025
Charles River Laboratories USD 196.14M 18.55M Dec/2025
Cooper Companies USD 373.1M 46.1M Dec/2025
Danaher USD 1.86B 166M Mar/2026
Dentsply International USD 383M 28M Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
Henry Schein USD 808M 48M Dec/2025
Idexx Laboratories USD 275.68M 10.58M Dec/2025
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
IQVIA Holdings USD 468M 46M Dec/2025
Masimo USD 128M 11.6M Dec/2025
McKesson USD 2.03B 44M Dec/2025
Mettler Toledo International USD 259.83M 11.43M Dec/2025
Revvity USD 251.73M 9.82M Dec/2025
Solventum Corp USD 759M 15M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Thermo Fisher Scientific USD 1.8B 179M Mar/2026
Veeva Systems USD 125.08M 3.11M Dec/2025
Waters USD 240.01M 25.78M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025
Zoetis USD 619M 40M Dec/2025